Two voltage-gated calcium channel subtypes-Ca V 1.2 and Ca V 1.3-underlie the major L-type Ca 2 þ currents in the mammalian central nervous system. Owing to their high sequence homology, the two channel subtypes share similar pharmacological properties, and at high doses classic calcium channel blockers, such as dihydropyridines, phenylalkylamines and benzothiazepines, do not discriminate between the two channel subtypes. Recent progress in treating Parkinson's disease (PD) was marked by the discovery of synthetic compound 8, which was reported to be a highly selective inhibitor of the Ca V 1.3 L-type calcium channels (LTCC). However, despite a previously reported IC 50 of B24 mM, in our hands inhibition of the full-length Ca V 1.3 42 by compound 8 at 50 mM reaches a maximum of 45%. Moreover, we find that the selectivity of compound 8 towards Ca V 1.3 relative to Ca V 1.2 B15 channels is greatly influenced by the b-subunit type and its splice isoform variants.
Results
Compound 8 is not selective against Ca V 1.3 with b2a-subunit. Compounds 1, 8 and PYT (1,3-bis(4-chlorophenethyl)pyrimidine-2,4,6(1H, 3H, 5H)-trione; Fig. 1 ) were synthesized according to the procedure reported by Kang. et al. 10 but with slight modifications (see Methods section). It has been reported that the newly discovered compound 8 inhibited B30 and 60% of Ca V 1.3 current at concentrations of 5 and 50 mM, respectively, whereas Ca V 1.2 channels were weakly responsive as 50 mM of compound 8 inhibited only close to 10% of its peak current 10 .
We have recently discovered that alternative splicing at the C terminus regulated the sensitivity of Ca V 1.3 channels towards DHPs; while the long-form Ca V 1.3 42 channel exhibited high sensitivity towards DHP; truncation of the C terminus immediately after the IQ domain via alternate use of exon 42a yielded the less sensitive Ca V 1.3 42a channel 8 . To determine whether the compound 8 may also have differential effects on different C-terminal splice forms, we first tested the sensitivity of rat Ca V 1.3 42 and Ca V 1.3 42a . In the presence of b2a contransfected with the Ca V 1.3 channels, the channel isoforms displayed very little run-down with repeated 1 s square pulse depolarization to test potential of 10 mV from a holding potential of À 70 mV at the frequency of 0.05 Hz (Figs 2b and 3b) . Surprisingly, 5 mM of compound 8 failed to significantly inhibit the peak Ca 2 þ current (I Ca ) of either Ca V 1.3 42 or Ca V 1.3 42a (Figs 2 and 3) as compared with the untreated controls. Moreover, 50 mM of compound 8 only inhibited 29.51±3.01 and 23.57±2.14% of the peak I Ca of Ca V 1.3 42 or Ca V 1.3 42a , respectively (Figs 2 and 3). In addition, Ca V 1.3 42 channels were blocked to a similar level with compound 8 obtained from an additional source ( Supplementary Fig. 1 ). In comparison, 78.85±2.63% of Ca V 1.3 42 current and 68.14±3.43% of Ca V 1.3 42a current could be robustly inhibited by 5 mM of nimodipine (Figs 2 and 3). As compound 8 has been reported to have little effect on Ca V 1.2 current, we tested its inhibition on the rat Ca V 1.2 B15 channels 11 . As compared with the Ca V 1.3, a slightly enhanced run-down effect (10.14 ± 3.98%) was observed for Ca V 1.2 B15 channels (Fig. 4b) . However, 34.97±4.39 and 44.03 ± 4.67% of Ca V 1.2 B15 current could be inhibited by 5 and 50 mM of compound 8, respectively, indicating a stronger inhibitory effect of compound 8 on Ca V 1.2 than Ca V 1.3 channels. As expected, 80.66 ± 2.82% of Ca V 1.2 B15 current was blocked by 5 mM nimodipine (Fig. 4) .
In addition, we evaluated the inhibitory activities of PYT and compound 1 against Ca V 1.3 and Ca V 1.2 channels 10 . Kang et al. 10 reported that PYT was the original scaffold that displayed an eightfold selectivity for Ca V 1.3, whereas compound 1 was one of the PYT analogues that was 28 times more selective for Ca V 1.3 channels. However, in our experiments, 5 mM of PYT and compound 1 did not significantly inhibit the peak I Ca of Ca V 1.3 42 (Supplementary Fig. 2 ). In addition, 5 mM of PYT inhibited 19.90 ± 2.59% of Ca V 1.3 42a current, whereas 5 mM of compound 1 had no effect on Ca V 1.3 42a channels ( Supplementary Fig. 3 ). In comparison, PYT and compound 1 also appeared to be more selective for Ca V 1.2 B15 showing 43.52±4.83% and 31.69±4.83% inhibition, respectively, ( Supplementary Fig. 4 ). The effect could not be a result of current run-down as little current decay was observed for the untreated Ca V 1.2 current upon prolonged pulses, and the current density of the recorded cells under all treatment groups were not significantly different in the study ( Supplementary Fig. 5 ).
Furthermore, we noted that the use of the original rat Ca V 1.3 42 (ref. 12) (Genbank accession no. AF370010) by Kang et al. 10 contained three mutations, including G244S, A1104V and V2123A, that have been shown to drastically alter both the biophysical and pharmacological properties of the channel 9, 13, 14 .
To test whether the use of uncorrected Ca V 1.3 42 channel, named here as Ca V 1.3 42_UC , could account for the lack of selectivity of compound 8 against Ca V 1.3 channels in the presence of b2a-subunit, we measured the sensitivity of Ca V 1.3 42_UC to either 5 and 50 mM compound 8 or 5 mM nimodipine with instead shorter 100 ms depolarizing pulse that was used by Kang et al. 10 While 5 mM compound 8 has little effect on Ca V 1.3 42_UC channels as compared with control treatment, only 15.75 ± 3.25% of the peak current could be inhibited by 50 mM compound 8, and expectedly 73.10 ± 3.48% of the current was blocked by 5 mM nimodipine (Fig. 5) . Hence, it was consistent that in the presence of b2a-subunit, Ca V 1.2 displayed higher sensitivity to compound 8 as compared with Ca V 1.3 channels.
b-subunit influences compound 8 selectivity. Although it has been shown that the presence of different b-subunits did not overtly affect the sensitivity of L-type channels towards DHP 15 , the use of different b-subunits such as b3 in Kang et al. 10 and b2a in the current study might account for the opposite selectivity of compound 8 on Ca V 1.2 and Ca V 1.3 channels observed in these two studies. To test this possibility, we first measured the effect of 50 mM compound 8 on Ca V 1.3 42 , Ca V 1.3 42_UC , Ca V 1.2 B15 and Ca V 1.3 42a channels co-transfected with b3-subunit. Interestingly, while B40% of the peak I Ca of Ca V 1.3 42 and the uncorrected Ca V 1.3 42_UC were similarly inhibited by 50 mM compound 8, Ca V 1.2 B15 and Ca V 1.3 42a channels displayed a slightly but significantly weaker sensitivity in comparison with Ca V 1.3 42 channels as 23.47 ± 2.60 and 29.05 ± 2.48% of respective peak currents were inhibited ( Fig. 6 and Supplementary Fig. 6 ). Additional experiments done using either b1-and b4-subunits produced results that demonstrated enhanced inhibitory effect of compound 8 on Ca V 1.3 42 as compared with Ca V 1.3 42_UC , Ca V 1.2 B15 and Ca V 1.3 42a channels. However, Ca V 1.2 B15 and Ca V 1.3 42a channels were inhibited to similar level by 50 mM compound 8 in the presence of b1-, b3-and b4-subunits ( Fig. 6 and Supplementary Fig. 6 ). Significantly, in the presence of b2a, Ca V 1.2 B15 still displayed higher sensitivity as compared with Ca V 1.3 42 , Ca V 1.3 42_UC and Ca V 1.3 42a , even when the currents were repeatedly recorded with a shorter100-ms depolarizing square pulse ( Fig. 6 and Supplementary Fig. 6 ).
Finally, we performed analysis of the correlation of the % of inhibition with the current density for each of the Ca V 1. Fig. 7 ).
Discussion PD is a debilitating movement disorder currently with no cure. The constant Ca 2 þ influx via the Ca V 1.3 channels enhances mitochondrial oxidative stress that could contribute towards the pathogenesis of PD. The presence of other possible pacemaking current underlied by hyperpolarization-activated and cyclic nucleotide-gated cation (HCN) channel suggested that it might be feasible to block Ca V 1.3 current without grossly affecting the normal physiological functions of SNc neurons 3 . The availability of a Ca V 1.3 channel-specific antagonist that could eventually replace non-selective L-type blockers such as DHPs would therefore be ideal for the therapeutic management of PD. In contrast to the IC 50 of 24.3 ±0.7 mM as determined using patch-clamp electrophysiology by Kang et al. 10 , our initial data with b2a-subunits revealed that the percentage inhibition of compound 8 on Ca v 1.3 channels at 50 mM was only 30% while at 5 mM no significant inhibition was observed. In contrast to the published report, the inhibition of Ca v 1.2 channels at 50 and 5 mM were 44% and 35%, respectively, indicating selectivity of compound 8 against Ca v 1.2 channels.
The initial failure to observe any selectivity of compound 8 in inhibiting Ca V 1.3 channels led us to investigate the effect of compound 8 with other b-subunits. However, while the Ca V 1.3 42 current was indeed more sensitive than Ca v 1.2 in the presence of b1-, b3-and b4-subunits, only 35-45% of the its peak currents could be blocked by 50 mM compound 8, and the percentage of inhibition on Ca V 1.2 B15 channels was a modest 10-15% less as compared with Ca V 1.3 42 channels.
To complicate the story further, the short-form Ca V 1.3 42a channels displayed similar level of sensitivity as compared with Ca V 1.2 B15 channels with either b1-, b3-or b4-subunit cotransfected. The Ca V 1.3 42a splice variant accounts for B30% of the total Ca V 1.3 transcripts in the substantial nigra region 7 . While the roles of different Ca V 1.3 splice variants in neurodegeneration of SNc neurons in the pathogenesis of PD awaits further clarification, the larger current density and more hyperpolarized-shifted I-V relationship implied a greater involvement of Ca V 1.3 42a current in driving the pacemaking acitivity in the SNc neurons as compared with the full-length Ca V 1.3 42 channels 8 .
In summary, the newly reported compound 8 is not a potent blocker of Ca V 1.3 channels as compared with the classical L-type blockers such as the DHPs. The selectivity of compound 8 on Ca V 1.3 42 over Ca V 1.2 B15 channels could be influenced strongly by the presence of various b-subunits and the compound 8 was not selective for Ca V 1.3 42a over Ca V 1.2 B15 channels in the presence of b1-, b3-or b4-subunit. Instead, in the presence of b2a, compound 8 strongly inhibits Ca V 1.2 B15 channels over all the Ca V 1.3 splice variants tested. Given the differential distribution of b-subunits and the varied expression levels of Ca v 1.3 channel variants across various neuronal types, brain regions and organs, the use of compound 8 as a Ca V 1.3-selective antagonist needs to be further clarified. Nonetheless, the quest for discovering a highly selective and potent compound targeting Ca V 1.3 channels is a highly worthwhile goal. (9) β3 (11) β4 (7) β1 (8) β2a (8) β3 (9) β4 (7) β1 (7) β2a (10) β3 (9) β4 ( 
Methods
General synthesis information. All commercially available reagents were bought from Sigma-Aldrich and Alfa Aesar, and used without further purification. Thin layer chromatography was performed using pre-coated plate (Merck silica gel 60, F254) and visualized with ultraviolet (UV) light. Flash column chromatography was carried out on Merck silica gel (230-400 mesh). 1 H and 13 C nuclear magnetic resonance (NMR) spectrums were recorded on Bruker ACF300 (300 MHz) or AMX 500 (500 MHz) spectrometer at 298 K, respectively. All J values are reported in Hz and chemical shift (d) reported in p.p.m. relative to tetramethylsilane. Abbreviations for signal multiplicities are as follow: singlet (s), doublet (d), triplet (t) and multiplet (m). Mass spectra were determined by electrospray ionization (ESI) on Finnigan TSQ 7000. High-performance liquid chromatography was performed using a Shimadzu LCMS-IT-TOF system with a Phenomenex Luma C18 column (50 Â 3.0 mm, 5 mm) using acetonitrile and 0.1% trifluoroacetic acid in water. The mobile phase has a flow rate of 5 ml min À 1 with gradient flow of acetonitrile increasing from 5 to 90%. UV/visible detector was set at a wavelength of 254 nm.
General synthetic procedure for compounds 1, 8 and PYT. Compounds 1, 8 and PYT were synthesized according to the procedure reported by Kang. et al. 10 but with slight modifications (Scheme 1). In brief, a solution of isocyanate (1 mmol) in dichloromethane (10 ml), the respective amine (1 mmol) was added and allowed to stir at room temperature overnight. The mixture was then diluted with dichloromethane (8 ml) and malonyl chloride (1.1 mmol) was added dropwise to the mixture at room temperature under vigorous stirring. Upon reaction completion (monitored by thin layer chromatography), the reaction mixture was concentrated and purified via flash column chromatography using hexane: ethyl acetate(3:1) as eluent to afford the final product. Compounds 1, 8 and PYT were characterized via 1 H and 13 C NMR, mass spectrometry (ESI) and melting point determination (Supplementary Figs 8,9 and 10). The characterization data were comparable to those reported by Kang et al. 10 Furthermore, the purity of each compound was determined by HPLC ( Supplementary Figs 11 and 12) , and the compounds were found to have a purity value of over 98%. amplifier (Molecular Devices, Union City, CA), were filtered at 1-5 kHz and sampled at 5-50 kHz, and the series resistance was typically o5 MO after 480% compensation. A P/4 protocol was used to subtract on-line the leak and capacitive transients. The currents were recorded by single square pulse from holding of À 70 to 10 mV for over 1 s or 100 ms with sweep interval of 20 s. Data were acquired using the software pClamp9 (Molecular Devices), and analysed and fitted using GraphPad Prism V software (San Diego, CA) and Microsoft (Seattle, WA) Excel. Data are expressed as mean values ± s.e.m.
Drug preparation. Stock solutions were prepared by dissolving compound PYT, 1, 8 and nimodipine (RBI) in DMSO to make a 100-mM stock solution and stored at À 20°C in the dark. Respective concentrations were freshly prepared in the bath solution from stock, and perfused (1 ml per min) into the whole recording chamber by gravity during current recording. The cell selected for patch-clamp recording were positioned as close to the outlet as possible. The external solutions were protected from light throughout the experiment.
